Outcome measures
Rheumatoid Arthritis, knee pain, pain
RHEUMATOID ARTHRITIS, SECONDARY, OSTEOARTHRITIS, PGA
The primary objective was to evaluate the effect of FCH on knee pain and function after 3 months of supplementation using the self-administered questionnaire KOOS. The secondary objectives were to evaluate the effects of FCH on knee pain and function using KOOS, knee pain at rest or while walking, PGA using VAS, QoL using SF-36, and the responder rate based on the Osteoarthritis Research Society International - Outcome Measures in Rheumatoid Arthritis Clinical Trials (OARSI-OMERACT) criteria after 1 month and 3 months. Product satisfaction and tolerance by self-administered questionnaires, as well as subjects’ compliance based on tablet counts and consumption of pain killers, were also assessed.